General Information of the Compound
| Compound ID |
CP0003676
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
1339928-25-4
2341AH
3S9RX35S5X
ABP001045
AKOS026750340
AOB6775
BCP06870
BDBM50188961
CHEMBL3622533
CUDC 907
CUDC-907
CUDC-907 (PI3K/HDAC Inhibi
CUDC907
DTXSID90712307
EX-A742
Fimepinostat
Fimepinostat [USAN]
GTPL8952
HMS3656H04
JOWXJLIFIIOYMS-UHFFFAOYSA-N
KS-00000TDO
MLS006010994
MolPort-023-293-550
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
PI3K/HDAC Inhibitor centn
SB16569
SCHEMBL1284705
UNII-3S9RX35S5X
ZINC73488511
s2759
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H24N8O4S
|
||||||||||||||||||
| Molecular Weight |
508.564
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cn1)-c1nc(N2CCOCC2)c2sc(CN(C)c3ncc(cn3)C(=O)NO)cc2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JOWXJLIFIIOYMS-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
1339928-25-4
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT02410, Histone deacetylase 11
Protein ID: PT00835, Histone deacetylase 2
Protein ID: PT00994, Histone deacetylase 4
Protein ID: PT00996, Histone deacetylase 5
Protein ID: PT01213, Histone deacetylase 6
Protein ID: PT01807, Histone deacetylase 7
Protein ID: PT01499, Histone deacetylase 8
Protein ID: PT01946, Histone deacetylase 9
Protein ID: PT01033, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
Protein ID: PT01443, Polyamine deacetylase HDAC10
Cell Viability or Cytotoxicity Assay
| Cell Line ID | Cell Line Name | Cell Line Organism | |
| CL000091 | MV4-11 | Homo sapiens (Human) | 1 |
| 1 |
IC50 = 0.43 nM
|
TI
LI
LO
TS
|
|
|---|---|---|---|
| CL000145 | NCI-H460 | Homo sapiens (Human) | 1 |
| 1 |
IC50 = 150 nM
|
TI
LI
LO
TS
|
|
Clinical Information about the Compound